Targeting BRAF V600E in metastatic colorectal cancer: where are we today? - ecancer
Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations | Scientific Reports
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
BRAF gene: From human cancers to developmental syndromes - ScienceDirect
Význam testování RAS u kolorektálního karcinomu
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories - ScienceDirect
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Cancers | Free Full-Text | Atypical BRAF and NRAS Mutations in Mucosal Melanoma
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
Decision algorithm used in our laboratory for the determination of... | Download Scientific Diagram
IJMS | Free Full-Text | The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia | Leukemia
Frontiers | The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
BRAF (gene) - Wikipedia
The classification of BRAF mutations and their signaling pathways.... | Download Scientific Diagram
A) The RAS/BRAF/MEK/ERK and the PI3K/AKT/mTOR pathways and (B) their... | Download Scientific Diagram
Cancers | Free Full-Text | Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Cancers | Free Full-Text | BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF: Cell
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Frontiers | Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA | Nature Medicine
